Journal profile · Neurosciences
Cellular and Molecular Neurobiology
ISSN 0272-4340 · eISSN 1573-6830 · Springer US · UNITED STATES · Bimonthly · Founded 1981
Cellular and Molecular Neurobiology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 7.4; hybrid open access; APC about USD 4,590; median 93 days to acceptance (16 articles, last 24 months); community-reported acceptance: easy; 122 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cellular and Molecular Neurobiology is published by Springer US and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Neuroscience and Neuropharmacology Research, Neuroinflammation and Neurodegeneration Mechanisms and Neurogenesis and neuroplasticity mechanisms, together about 30.4% of its articles. Its main subfields are Cellular and Molecular Neuroscience and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Cellular and Molecular Neurobiology publishes original research concerned with the analysis of neuronal and brain function at the cellular and subcellular levels. The journal offers timely, peer-reviewed articles that describe anatomic, genetic, physiologic, pharmacologic, and biochemical approaches to the study of neuronal function and the analysis of elementary mechanisms. Studies are presented on isolated mammalian tissues and intact animals, with investigations aimed at the molecular mechanisms or neuronal responses at the level of single cells. Cellular and Molecular Neurobiology also presents studies of the effects of neurons on other organ systems, such as analysis of the electrical or biochemical response to neurotransmitters or neurohormones on smooth muscle or gland cells
From the journal's Aims & Scope
Research area (LetPub): Neurosciences
Editorial board by country: 5 in mainland China (about 8%); most named United States 21, Italy 7, Mainland China 5, Germany 5, Argentina 4 (66 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neuroscience and Neuropharmacology ResearchNeuroscience14.9%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience8.9%
- Neurogenesis and neuroplasticity mechanismsNeuroscience6.7%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology5.6%
- Alzheimer's disease research and treatmentsMedicine5.4%
- Nerve injury and regenerationNeuroscience5.3%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology4.9%
- Neuropeptides and Animal PhysiologyNeuroscience4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Neurosciences | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.4LetPub ·
- Impact factor (publisher) 2025
- 7.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.3Publisher website ·
- CiteScore 2026-06
- 12.3LetPub ·
- SJR 2026-06
- 1.59LetPub ·
- SNIP 2026-06
- 1.22LetPub ·
- h-index
- 81LetPub ·
- h-index
- 128OpenAlex ·
- i10-index
- 2,771OpenAlex ·
- 2-year mean citedness
- 5.59OpenAlex ·
- Self-citation rate
- 1.4%LetPub ·
- Share of gold OA articles
- 69.45%LetPub ·
Volume
- Articles per year
- 115LetPub ·
- Downloads per year (publisher) 2025
- 785,900Publisher website ·
Articles by year OpenAlex count · 4,083 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 177 | 177 | 127 |
| 2025 | 122 | 122 | 834 |
| 2024 | 77 | 77 | 1,140 |
| 2023 | 132 | 132 | 2,758 |
| 2022 | 140 | 140 | 2,878 |
| 2021 | 155 | 155 | 3,566 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
93 daysMedian, submission to acceptance · P25–P75 65 days – 132 days
- Acceptance to online
- median 12 days (16 articles)
- Submission to online
- median 102 days
- Sample
- 16 articles with submission and acceptance dates (22 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,590 / EUR 3,490 / GBP 2,890 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers3, by deadline
- Artificial Intelligence for neurodegenerative diseases: from biomarkers to therapeuticsDeadline
- Advances in Drug Development for Ischemic Stroke and Related NeuropharmacologyDeadline
- Brain Renin–Angiotensin System in Aging and Neurodegenerative Diseases: Mechanisms, Biomarkers, and Therapeutic OpportunitiesDeadline
What to prepare3 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Author–date
Article types accepted8, with length limits
- commentaryOriginal Paper, Commentary, Review Paper, Short Communication Cellular and Molecular Neurobiology will publish papers which conform to any of the following cate…Length not stated
- editorialOriginal Paper, Commentary, Review Paper, Short Communication Cellular and Molecular Neurobiology will publish papers which conform to any of the following cate…Length not stated
- literature reviewOriginal Paper, Commentary, Review Paper, Short Communication Cellular and Molecular Neurobiology will publish papers which conform to any of the following cate…Length not stated
- original paperOriginal Paper, Commentary, Review Paper, Short Communication Cellular and Molecular Neurobiology will publish papers which conform to any of the following cate…Length not stated
- research articleOriginal Paper, Commentary, Review Paper, Short Communication Cellular and Molecular Neurobiology will publish papers which conform to any of the following cate…Length not stated
- reviewOriginal Paper, Commentary, Review Paper, Short Communication Cellular and Molecular Neurobiology will publish papers which conform to any of the following cate…Length not stated
- review paperOriginal Paper, Commentary, Review Paper, Short CommunicationLength not stated
- short communicationOriginal Paper, Commentary, Review Paper, Short Communication Cellular and Molecular Neurobiology will publish papers which conform to any of the following cate…main text ≤ 1,500 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data Availability
Data availability statement required Model summary
All original research must include a Data Availability Statement. Data Availability Statements should provide information on where data supporting the results reported in the article can be found. Statements should include, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. When it is not possible to share research data publicly, for instance when in…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
Springer publishing ethics policy Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Permissions required for previously published material Model summary
Articles in Springer Nature open access journals do not require transfer of copyright as the copyright remains with the author. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Cellular and Molecular Neurobiology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if a guest editor authors an article in their issue/collection, they will not handle the peer review process. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1981
- ISSN
- 0272-4340
- Electronic ISSN
- 1573-6830
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Cellular and Molecular Neurobiology
What CAS zone is Cellular and Molecular Neurobiology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cellular and Molecular Neurobiology is in Zone 4 of Medicine, and in Zone 4 of the minor category Cell Biology / Neurosciences. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cellular and Molecular Neurobiology?
The latest impact factor listed by LetPub is 7.4; CiteScore 12.3, h-index 128.
How long does peer review take at Cellular and Molecular Neurobiology?
Based on the dates recorded on 16 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 93 days (interquartile range 65–132 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cellular and Molecular Neurobiology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Author–date. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cellular and Molecular Neurobiology based?
Of the 66 board members whose country the journal's board page names, 5 (about 8%) are in mainland China; the countries named most often are United States (21), Italy (7) and Mainland China (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Cellular and Molecular Neurobiology?
According to LetPub and DOAJ records, Cellular and Molecular Neurobiology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Cellular and Molecular Neurobiology open access, and what is the APC?
Cellular and Molecular Neurobiology is a hybrid journal. For open-access publication: APC about USD 4,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .